Millenium Pharmaceuticals

Call
Website
921 Industry Dr
Tukwila, WA 98188
+1 (206) 575-2282
http://yellowpages.com

Takeda Pharmaceuticals USA, based in Seattle, WA, is a leading global pharmaceutical company dedicated to improving the health and well-being of patients worldwide. With a focus on innovation and patient care, Takeda strives to address key societal challenges and create value for society through purpose-led sustainability initiatives.

Driven by a commitment to diversity, equity, and inclusion, Takeda is transforming into an agile and innovative pharmaceutical leader, offering a wide range of patient services and assistance. Through research and development, Takeda aims to reduce time to diagnosis, improve access to care, and address health inequities in communities across the United States.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Pharmaceuticals, Roofing contractor

Alpine Pharmaceutical

Alpine Pharmaceutical is a reputable company based in Auburn, WA, specializing in the development and distribution of pharmaceutical products. With a focus on quality and innovation, Alpine Pharmaceutical serves a diverse range of clients in the healthcare industry, providing essential solutions to meet their needs.Generated from their business information
Drugs and drug proprietaries

Trubion Pharmaceuticals, Inc

Trubion Pharmaceuticals Inc., based in Seattle, WA, is at the forefront of innovative research focusing on glycan-based treatments and glycobiology applications within contemporary healthcare. The company is dedicated to exploring the therapeutic potential of glycosylation and glycoproteomics, emphasizing their significance in drug development and bioconjugation. With a commitment to advancing personalized medicine, Trubion is engaged in transformative research that leverages mass spectrometry and carbohydrate-protein interactions to enhance therapeutic efficacy, particularly in monoclonal antibodies. Their ongoing investigations aim to unlock new pathways in cancer diagnostics and therapeutic innovation, positioning them as leaders in the field of glycan research. Generated from the website
Securities flotation companies

Faraday Pharmaceuticals

Faraday Pharmaceuticals, based in Seattle, WA, is a pioneering biotech company focused on developing innovative solutions for cardiovascular health. Their lead program, FDY-5301, targets ischemia-reperfusion injury to reduce cardiac damage and heart failure in patients who have experienced myocardial infarctions. Founded by Dr. Mark Roth of the Fred Hutchinson Cancer Center, Faraday Pharmaceuticals is dedicated to investigating sodium iodide as a novel approach to addressing ischemia-reperfusion injury. Their Phase 3 clinical trial, Iocyte AMI-3, aims to evaluate the potential of FDY-5301 in reducing heart failure and cardiovascular death among patients with anterior ST-elevation myocardial infarction.Generated from the website
United States›Washington›Tukwila›Millenium Pharmaceuticals

Partial Data by Foursquare.